Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Nature Communications|October 4, 2023
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expressionElizabeth Heyes, Anna S Wilhelmson, Anne Wenzel, et al.
Nature Communications|November 26, 2022
Decoding molecular programs in melanoma brain metastasesJosefine Radke, Elisa Schumann, Julia Onken, et al.
Nature Communications|May 28, 2021
Exploring protein hotspots by optimized fragment pharmacophoresDávid Bajusz, Warren S Wade, Grzegorz Satała, et al.
Nature Communications|May 19, 2025
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12Selina Troester, Thomas Eder, Nadja Wukowits, et al.
Molecular Systems Biology|November 6, 2013
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanismsJiannong Li, Keiryn Bennett, Alexey Stukalov, et al.
ACS Pharmacology & Translational Science|December 19, 2024
Off-Target Inhibition of Human Dihydroorotate Dehydrogenase (hDHODH) Highlights Challenges in the Development of Fat Mass and Obesity-Associated Protein (FTO) InhibitorsMarco Tarullo, Guillermo Fernandez Rodriguez, Alessia Iaiza, et al.
Nature Communications|May 20, 2018
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrityAnna Skucha, Jessica Ebner, Johannes Schmöllerl, et al.
Frontiers in Plant Science|October 14, 2021
Impact of Specific N-Glycan Modifications on the Use of Plant-Produced SARS-CoV-2 Antigens in Serological AssaysJennifer Schwestka, Julia König-Beihammer, Yun-Ji Shin, et al.
The Journal of Clinical Investigation|December 5, 2017
STAT5BN642H is a driver mutation for T cell neoplasiaHa Thi Thanh Pham, Barbara Maurer, Michaela Prchal-Murphy, et al.
Pageof 8